A clinical trial to study the effect of dexmeditomidine in two different routes of administration in patients undergoing elective and emergency femur surgeries.

Dexmedetomidine as an Adjunct to Bupivacaine in Ultrasound Guided Fascia Iliaca Compartmental Block for Femur Surgeries: A Randomized Controlled Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/03/006757

Enrollment

Registered

2016-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who have got femur bone frature

Interventions

Intervention1: Local Dexmeditomedine: In one arm, Dexmeditomedine will be added as 1 microgram/kg diluted to 2ml by adding normal saline to the local anesthetic bupivacaine 40 ml of 0.25% locally for

Eligibility

Inclusion criteria

Inclusion criteria: 1)Elective and emergency Femur bone surgeries, 2)American society of Anesthesiologist 1,2,3 physical status patients.

Exclusion criteria

Exclusion criteria: 1)Coagulation disorders 2)Previous femoral bypass surgeries 3)Inflammation and infection over injection sites 4)Allergic to local anesthetics

Design outcomes

Primary

Measure	Time frame
Requirement of Perioperative analgesic agents Duration of analgesiaTimepoint: Requirement of perioperative analgesic agents at the time of skin incision of the surgery, requirement of analgesic agents intraoperatively and 24 hours post operatively.	—

Secondary

Measure	Time frame
Perioperative hemodynamic outome Side effect profileTimepoint: 1.5 Years	—

Countries

India

Contacts

Public ContactDr Sakthirajan Paneerselvam

JIPMER

sakthiab8@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026